Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Non-LTR Retrotransposons

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...

Alternative RNA Splicing

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Network methods for diagonal integration of unpaired single-cell multiomics data: a review.

Bioinformatics (Oxford, England)·2026

Same author

Adenocarcinoma of the small intestine cohort: prospectively collecting real-world data to improve care and quality of life for patients with a rare cancer.

Acta oncologica (Stockholm, Sweden)·2026

Same author

In vitro models of cell competition: current approaches and future directions.

Oncogene·2026

Same author

Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncology.

NPJ precision oncology·2026

Same author

The effect of a person-centred lifestyle programme on cancer-related fatigue in colorectal cancer survivors: a randomised trial.

The British journal of nutrition·2025

Same author

Sexual health at the end of life in patients with advanced cancer and their partners. Results of a Dutch prospective longitudinal study (eQuiPe).

Palliative medicine·2025

Search research articles

Related Experiment Video

Updated: May 8, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Transcriptomic subtyping of gastrointestinal malignancies.

Tim R de Back¹, Sander R van Hooff¹, Dirkje W Sommeijer²

¹Cancer Center Amsterdam, Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands; Amsterdam Gastroenterology Endocrinology Metabolism, Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands; Oncode Institute, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.

Trends in Cancer

|July 17, 2024

Summary

This summary is machine-generated.

Transcriptomic subtyping reveals shared biological features across gastrointestinal (GI) cancers, offering prognostic and predictive value. This approach captures complex tumor states, impacting clinical management and future research directions.

Keywords:

colorectal cancer gastric cancer gastrointestinal malignancies pancreatic ductal adenocarcinoma personalized medicine transcriptomic subtyping

More Related Videos

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

Related Experiment Videos

Last Updated: May 8, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

Area of Science:

Oncology
Genomics
Molecular Biology

Background:

Gastrointestinal (GI) cancers exhibit significant heterogeneity at multiple molecular levels.
Molecular profiling, including transcriptomic classification, is crucial for understanding tumor complexity.
Transcriptomic subtyping integrates genetic, epigenetic, cancer cell-intrinsic, and tumor microenvironment (TME) data.

Purpose of the Study:

To review methodologies for transcriptomic subtyping in GI malignancies.
To discuss proposed transcriptomic taxonomies for GI cancers.
To highlight challenges and opportunities for clinical implementation of transcriptomic profiling.

Main Methods:

Unsupervised learning approaches for transcriptomic data analysis.
Integration of multi-omics data for comprehensive subtyping.
Comparative analysis of existing transcriptomic subtyping systems.

Main Results:

Transcriptomic subtyping identifies shared biological features across diverse GI cancers.
Subtypes demonstrate prognostic and predictive significance.
Subtypes reflect dynamic phenotypic states within tumors and during disease progression.

Conclusions:

Transcriptomic subtyping provides a powerful framework for classifying GI malignancies.
Accurate subtyping has direct implications for clinical decision-making and treatment strategies.
Future transcriptomic profiling efforts are essential for optimizing clinical impact and advancing personalized oncology.